(Q35583432)

9 August 2017

1 reference

title

Role of the microenvironment in chronic lymphocytic leukaemia (English)

1 reference

9 August 2017

author name string

Federico Caligaris-Cappio

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2003.04679.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616995

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04679.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04679.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

British Journal of Haematology

1 April 2024

published in

1 reference

9 August 2017

volume

123

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

380-388

1 reference

Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04679.X

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

How immunology is reshaping clinical disciplines: the example of haematology

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

B-cell chronic lymphocytic leukemia: a bird of a different feather

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Genomic aberrations and survival in chronic lymphocytic leukemia

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Regulation of hemopoiesis by bone marrow stromal cells and their products

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Chronic B cell malignancies and bone marrow microenvironment

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Genetic susceptibility to chronic lymphocytic leukemia

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Integrins and GTPases in tumour cell growth, motility and invasion

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

1 April 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Cellular origin of human B-cell lymphomas.

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Control of apoptosis and mitotic spindle checkpoint by survivin

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Mechanism of antigen-driven selection in germinal centres

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment

1 April 2024

51

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation

1 April 2024

52

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia

1 April 2024

54

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

1 April 2024

55

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

1 April 2024

56

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The triterpenoid CDDO induces apoptosis in refractory CLL B cells

1 April 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Follicular dendritic cells in non-Hodgkin lymphomas: Localisation, characterisation and pathophysiological aspects

1 April 2024

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Production of cytokines by human B cells in health and disease

1 April 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The Survivin saga goes in vivo

1 April 2024

63

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia

1 April 2024

64

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 April 2024

65

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Chronic lymphocytic leukemia

1 April 2024

66

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study

1 April 2024

67

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

1 April 2024

68

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire

1 April 2024

69

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The occurrence and significance of V gene mutations in B cell-derived human malignancy

1 April 2024

72

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.

1 April 2024

73

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

Evolution of autoantibody responses via somatic hypermutation outside of germinal centers

1 April 2024

77

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04679.X

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference